Abdulgabar Salama

6.1k total citations · 1 hit paper
141 papers, 4.4k citations indexed

About

Abdulgabar Salama is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Abdulgabar Salama has authored 141 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Hematology, 30 papers in Genetics and 30 papers in Physiology. Recurrent topics in Abdulgabar Salama's work include Blood groups and transfusion (77 papers), Platelet Disorders and Treatments (59 papers) and Erythrocyte Function and Pathophysiology (28 papers). Abdulgabar Salama is often cited by papers focused on Blood groups and transfusion (77 papers), Platelet Disorders and Treatments (59 papers) and Erythrocyte Function and Pathophysiology (28 papers). Abdulgabar Salama collaborates with scholars based in Germany, United States and Switzerland. Abdulgabar Salama's co-authors include H. Kiesewetter, Beate Mayer, H. Radtke, James B. Bussel, Thomas Dörner, Kamran Movassaghi, Axel Prüß, Norbert Ahrens, C. Mueller‐Eckhardt and Corinna Opitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Abdulgabar Salama

140 papers receiving 4.3k citations

Hit Papers

Superior antigen cross-pr... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
    2010 627 citations Abdulgabar Salama et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdulgabar Salama Germany 32 2.4k 1.2k 770 621 500 141 4.4k
Simon Panzer Austria 41 3.2k 1.4× 569 0.5× 525 0.7× 371 0.6× 622 1.2× 289 6.2k
Xavier Le Loët France 42 1.3k 0.5× 1.4k 1.2× 644 0.8× 281 0.5× 261 0.5× 198 5.4k
Gordon L. Phillips United States 26 1.6k 0.7× 643 0.6× 514 0.7× 437 0.7× 291 0.6× 87 3.8k
Anand Padmanabhan United States 26 1.5k 0.6× 885 0.8× 591 0.8× 249 0.4× 219 0.4× 70 3.9k
Jan‐Stephan Sanders Netherlands 34 1.8k 0.7× 875 0.8× 802 1.0× 270 0.4× 185 0.4× 168 4.2k
Hideto Kameda Japan 38 1.2k 0.5× 1.2k 1.0× 631 0.8× 220 0.4× 180 0.4× 196 4.3k
Patrick Durez Belgium 38 2.4k 1.0× 2.2k 1.9× 1.3k 1.7× 209 0.3× 324 0.6× 205 7.2k
Nicole A. Aqui United States 18 862 0.4× 1.3k 1.1× 569 0.7× 213 0.3× 262 0.5× 41 3.4k
Sriram Krishnaswami United States 32 2.2k 0.9× 1.4k 1.2× 1.3k 1.6× 221 0.4× 404 0.8× 59 6.1k
Andrew M. Yeager United States 30 2.8k 1.2× 689 0.6× 805 1.0× 254 0.4× 231 0.5× 91 4.5k

Countries citing papers authored by Abdulgabar Salama

Since Specialization
Citations

This map shows the geographic impact of Abdulgabar Salama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulgabar Salama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulgabar Salama more than expected).

Fields of papers citing papers by Abdulgabar Salama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulgabar Salama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulgabar Salama. The network helps show where Abdulgabar Salama may publish in the future.

Co-authorship network of co-authors of Abdulgabar Salama

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulgabar Salama. A scholar is included among the top collaborators of Abdulgabar Salama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulgabar Salama. Abdulgabar Salama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mayer, Beate, et al.. (2019). Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies. Cellular Physiology and Biochemistry. 53(3). 453–464. 5 indexed citations
3.
Mayer, Beate, et al.. (2018). Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells. Transfusion Medicine and Hemotherapy. 45(6). 429–436. 19 indexed citations
4.
5.
Wong, Raymond, Mansoor N. Saleh, Abderrahim Khélif, et al.. (2017). Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood. 130(23). 2527–2536. 215 indexed citations
6.
Kamhieh‐Milz, Julian, et al.. (2017). Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP). Clinical Immunology. 188. 74–80. 16 indexed citations
7.
Mayer, Beate, et al.. (2017). Eryptosis in autoimmune haemolytic anaemia. European Journal Of Haematology. 100(1). 36–44. 23 indexed citations
8.
Mielke, Orell, Stefano Fontana, Vesselina Goranova‐Marinova, et al.. (2017). Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility. Transfusion. 57(11). 2629–2638. 12 indexed citations
9.
Saleh, Mansoor N., James B. Bussel, Abderrahim Khélif, et al.. (2016). Improvements in Patient Health-Related Quality of Life (HRQoL) with Clinical Efficacy in Patients Treated with Eltrombopag: Final Results from the Long-Term, Open-Label Extend Study. Blood. 128(22). 3742–3742. 3 indexed citations
10.
Mayer, Beate, et al.. (2015). Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre. Transfusion Medicine and Hemotherapy. 42(5). 333–339. 51 indexed citations
11.
Kamhieh‐Milz, Julian, Matthias E. Futschik, Omid Khorramshahi, et al.. (2014). Differentially Expressed MicroRNAs in Maternal Plasma for the Noninvasive Prenatal Diagnosis of Down Syndrome (Trisomy 21). BioMed Research International. 2014. 1–9. 21 indexed citations
12.
Quinti, Isabella, Martha M. Eibl, Helen Chapel, et al.. (2014). Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe. Frontiers in Immunology. 5. 629–629. 68 indexed citations
13.
Mayer, Beate, et al.. (2012). The first example of a patient with etoricoxib‐induced immune hemolytic anemia. Transfusion. 53(5). 1033–1036. 7 indexed citations
14.
Lachmann, Nils, Paul I. Terasaki, Klemens Budde, et al.. (2009). Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts. Transplantation. 87(10). 1505–1513. 271 indexed citations
15.
Salama, Abdulgabar, Bettina Temmesfeld‐Wollbrück, Stefan Hippenstiel, et al.. (2004). A new strategy for the prevention of IgA anaphylactic transfusion reactions. Transfusion. 44(4). 509–511. 12 indexed citations
16.
17.
Prüß, Axel, Ulrich Kalus, H. Radtke, et al.. (2003). Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfusion and Apheresis Science. 30(1). 41–46. 44 indexed citations
18.
Schwella, N., Andrea Braun, Norbert Ahrens, Oliver Rick, & Abdulgabar Salama. (2003). Leukapheresis after high‐dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft. Transfusion. 43(2). 259–264. 8 indexed citations
19.
Carstanjen, Dirk, et al.. (2001). Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Experimental Hematology. 29(7). 812–821. 21 indexed citations
20.
Salama, Abdulgabar & C. Mueller‐Eckhardt. (1992). Use of Rh Antibodies in the Treatment of Autoimmune Thrombocytopenia. Transfusion Medicine Reviews. 6(1). 17–25. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Panzer Breakdown of academic impact, for papers by Xavier Le Loët Breakdown of academic impact, for papers by Gordon L. Phillips Breakdown of academic impact, for papers by Anand Padmanabhan Breakdown of academic impact, for papers by Jan‐Stephan Sanders Breakdown of academic impact, for papers by Hideto Kameda Breakdown of academic impact, for papers by Patrick Durez Breakdown of academic impact, for papers by Nicole A. Aqui Breakdown of academic impact, for papers by Sriram Krishnaswami Breakdown of academic impact, for papers by Andrew M. Yeager
Rankless by CCL
2026